Skip to main content

Day: August 14, 2023

Gulf Resources Announces Results for the Second Quarter and Six Months Ending June 30, 2023

SHOUGUANG, China, Aug. 14, 2023 (GLOBE NEWSWIRE) — Gulf Resources, Inc. (Nasdaq: GURE) (“Gulf Resources”, “we,” or the “Company”), a leading manufacturer of bromine, crude salt and specialty chemical products in China, today announced financial results for the second quarter and six months ending June 30, 2023. At the end of this press release you will see our income statement, balance sheet, and cash flow statement. Our 10-Q filed with the SEC describes all the business segments of the company. While we normally cover these segments first, this quarter we will provide investors with context about the Chinese economy in general and our industries in particular so you can better understand the current direction of the company. The Chinese Economy In the second quarter of 2023, the Chinese economy continued...

Continue reading

Solid Biosciences Provides Second Quarter Business Update and Financial Results

– On track to submit IND in Q4 2023 for SGT-003, a next-generation gene therapy for patients with Duchenne muscular dystrophy (Duchenne) – – Executed licensing agreement for development and commercialization of gene therapies in certain fatal cardiac disorders – – Company ends second quarter with approximately $160.2 million in cash and investments; Anticipated cash runway into 2025 – CHARLESTOWN, Mass., Aug. 14, 2023 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing genetic medicines for neuromuscular and cardiac diseases, today reported financial results for the second quarter ended June 30, 2023, and provided a business update. “We made strong progress this quarter across multiple programs in our pipeline of genetic medicines and remain on track to submit an IND for SGT-003 in the fourth...

Continue reading

Checkpoint Therapeutics Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights

Biologics License Application for cosibelimab under review by U.S. FDA; Successful mid-cycle meeting with U.S. FDA completed; PDUFA goal date of January 3, 2024 Longer-term cosibelimab results demonstrate substantial increases in complete response rates and continued favorable safety profile in advanced cutaneous squamous cell carcinoma Unique potential for cosibelimab to address a large unmet clinical need in immunosuppressed and high risk patients WALTHAM, Mass., Aug. 14, 2023 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced financial results for the second quarter ended June 30, 2023, and recent corporate highlights. “We continue to work with the U.S. Food and Drug Administration (“FDA”) toward the January 3, 2024 action...

Continue reading

Cingulate Inc. Reports Second Quarter 2023 Financial Results and Provides Clinical and Business Update

Werth Family Investment Associates Provides Additional Capital InvestmentPhase 3 Adult Efficacy and Safety Trial of CTx-1301 Data ReleasedCTx-1301 Phase 3 Pediatric and Adolescent Studies Underway KANSAS CITY, Kan., Aug. 14, 2023 (GLOBE NEWSWIRE) — Cingulate Inc. (NASDAQ: CING) (Cingulate or the Company), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today provided financial results for the quarter ended June 30, 2023, as well as a clinical and business update. Among other highlights, the Company announced a $1 million dollar investment from Werth Family Investment Associates LLC (WFIA), top-line results following the completion of a Phase 3 Adult Efficacy and Safety...

Continue reading

Sachem Capital Reports Second Quarter 2023 Results – Produces Record Revenue Growth of 31.2% to $16.5 Million

– Company to Host Webcast and Conference Call – BRANFORD, Conn., Aug. 14, 2023 (GLOBE NEWSWIRE) — Sachem Capital Corp. (NYSE American: SACH) announced its financial results for the quarter ended June 30, 2023. The company will host a webcast and conference Tuesday, August 15, 2023 at 8:00 a.m. Eastern Time to discuss in greater detail its financial performance and operating results for the second quarter. John Villano, CPA, Sachem Capital’s Chief Executive Officer, stated, “We produced another strong quarter of earnings as we effectively navigated the volatility and uncertainty in the current economy. Armed with enhanced underwriting and a high-quality team, Sachem remains steadfast in its ability to originate loans that minimize risk and insulate our portfolio. We continue to explore opportunities to expand our lending...

Continue reading

Nova LifeStyle, Inc. Reports Second Quarter FY 2023 Results

LOS ANGELES, Aug. 14, 2023 (GLOBE NEWSWIRE) — Nova LifeStyle, Inc. (NASDAQ: NVFY) (“Nova LifeStyle” or the “Company”) today announced its financial results for the second quarter ended June 30, 2023. Key Financial Highlights: Operating Results for the Three Months Ended June 30, 2023Net sales for three months ended June 30, 2023 were $4.5 million, an increase of 17% from $3.8 million in the same period of 2022.Gross profit was $1.4 million compared to ($3.5 million) loss in the same period of 2022.Net loss was ($539 thousand), compared to ($5.7 million) loss in the same period of 2022.Operating Results for the Six Months Ended June 30, 2023Net sales for the six months ended June 30, 2023 were $6.3 million, a decrease of 15% from $7.5 million in the same period 2022.Gross profit was $2.1 million, compared to ($2.0...

Continue reading

Natural Gas Services Group, Inc. Reports Second Quarter 2023 Financial and Operating Results

Midland, Texas, Aug. 14, 2023 (GLOBE NEWSWIRE) — Second Quarter 2023 HighlightsRental revenue of $24.1 million, an increase of 33% when compared to the second quarter of 2022 and 6% when compared to the first quarter of 2023. Net income of $504,000, or $0.04 per basic share, as compared to a net loss of $70,000 in the second quarter of 2022 and net income of $370,000 when compared to the first quarter of 2023. Adjusted EBITDA of $9.9 million, compared to $6.7 million in the second quarter of 2022 and $7.8 million in the first quarter of 2023. Please see Non-GAAP Financial Measures – Adjusted EBITDA, below.MIDLAND, Texas August 15, 2023 (GLOBE NEWSWIRE) Natural Gas Services Group, Inc. (“NGS” or the “Company”) (NYSE:NGS), a leading provider of natural gas compression equipment, technology and services to the energy industry,...

Continue reading

CompoSecure Reports Second Quarter 2023 Financial Results

– Secures Long-Term Contract Renewal for One of Its Largest Customers – – Reaffirms 2023 Net Sales and Adjusted EBITDA Guidance – SOMERSET, N.J., Aug. 14, 2023 (GLOBE NEWSWIRE) — CompoSecure, Inc. (Nasdaq: CMPO), a leader in metal payment cards, security, and authentication solutions, today announced its financial and operating results for the second quarter ended June 30, 2023. “We continue to demonstrate the performance and consistency of our business as our second quarter results were in-line with our expectations despite continued macroeconomic uncertainties,” said Jon Wilk, President and CEO of CompoSecure. “General sentiment from our customers around the premium payment card market remained positive during the quarter. We are poised to continue to drive growth and cash flow generation for the remainder of the year, delivering...

Continue reading

Quipt Home Medical Reports Strong Operational Performance With Record Third Quarter Fiscal 2023 Financial Results Posting Revenue Growth of 64% and Adjusted EBITDA Growth of 80%

Posts Strong Adjusted EBITDA Margin of 23% and Sequential Organic Growth of 4% CINCINNATI, Aug. 14, 2023 (GLOBE NEWSWIRE) — Quipt Home Medical Corp. (the “Company” or “Quipt“) (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its third quarter fiscal 2023 financial results and operational highlights. These results pertain to the three and nine months ended June 30, 2023, and are reported in U.S. Dollars. Quipt will host its Earnings Conference Call on Tuesday, August 15, 2023, at 10:00 a.m. (ET). The dial-in number is 1 (800) 319-4610 or 1 (604) 638-5340. The live audio webcast will be accessible on the investor section of the Company’s website through the following link: www.quipthomemedical.com. Financial Highlights:Revenues for fiscal Q3 2023...

Continue reading

Rumble Reports Strong Second Quarter 2023 Results

~ Record Quarterly Revenue To-Date of $25.0 Million, an Increase of 468% Compared to Q2 2022 ~ ~ Company Strategically Diversifies Content with the Addition of Top Influencers Across Gaming, Culture and Lifestyle ~ LONGBOAT KEY, Fla., Aug. 14, 2023 (GLOBE NEWSWIRE) — Rumble Inc. (Nasdaq: RUM) (“Rumble” or the “company”), the popular video-sharing platform, today announced financial results for the fiscal quarter ended June 30, 2023. Q2 2023 Highlights and Key ItemsDriven by a pool of exclusive premium content and continued early maturation of advertising tools, second quarter revenue increased 468% to $25.0 million, compared to $4.4 million in the second quarter of 2022, and $17.6 million in the first quarter of 2023. Strong consumption with average estimated Minutes Watched Per Month (“MWPM”) increasing by 46% to 11.8 billion...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.